Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Organigram Holdings Inc. (OGI : NSDQ)
 
 • Company Description   
Organigram Holdings Inc. is a licensed producer of cannabis and cannabis-derived products primarily in Canada, through a wholly owned subsidiary. Organigram Holdings Inc. is based in Moncton, Canada.

Number of Employees: 736

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.23 Daily Weekly Monthly
20 Day Moving Average: 6,181,571 shares
Shares Outstanding: 313.69 (millions)
Market Capitalization: $385.84 (millions)
Beta: 0.36
52 Week High: $3.52
52 Week Low: $1.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -29.31% -22.83%
12 Week -19.61% -13.11%
Year To Date -29.71% -16.75%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
35A ENGLISH DR.
-
MONCTON,A3 E1E 3X3
CAN
ph: 506-384-1571
fax: -
None http://www.organigram.ca
 
 • General Corporate Information   
Officers
Beena Goldenberg - Chief Executive Officer
Peter Amirault - Executive Chairman
Derrick West - Chief Financial Officer
Megan McCrae - Senior Vice President
Nathalie Batten - Vice President

Peer Information
Organigram Holdings Inc. (BJCT)
Organigram Holdings Inc. (CADMQ)
Organigram Holdings Inc. (APNO)
Organigram Holdings Inc. (UPDC)
Organigram Holdings Inc. (IMTIQ)
Organigram Holdings Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 68620P101
SIC: 2834
Fiscal Year
Fiscal Year End: August
Last Reported Quarter: 02/01/22
Next Expected EPS Date: 07/12/22
Share - Related Items
Shares Outstanding: 313.69
Most Recent Split Date: (:1)
Beta: 0.36
Market Capitalization: $385.84 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.02 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.11 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/12/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.96
Price/Cash Flow: -
Price / Sales: 4.51
EPS Growth
vs. Year Ago Period: 77.78%
vs. Previous Quarter: 33.33%
Sales Growth
vs. Year Ago Period: 117.98%
vs. Previous Quarter: 3.54%
ROE
02/28/22 - -12.28
11/30/21 - -18.09
08/31/21 - -22.55
ROA
02/28/22 - -10.75
11/30/21 - -15.16
08/31/21 - -17.75
Current Ratio
02/28/22 - 5.04
11/30/21 - 8.40
08/31/21 - 9.92
Quick Ratio
02/28/22 - 3.84
11/30/21 - 6.83
08/31/21 - 8.06
Operating Margin
02/28/22 - -56.28
11/30/21 - -86.32
08/31/21 - -111.15
Net Margin
02/28/22 - -32.87
11/30/21 - -107.01
08/31/21 - -163.38
Pre-Tax Margin
02/28/22 - -34.16
11/30/21 - -108.45
08/31/21 - -165.11
Book Value
02/28/22 - 1.29
11/30/21 - 1.28
08/31/21 - 1.26
Inventory Turnover
02/28/22 - 1.89
11/30/21 - 2.21
08/31/21 - 2.25
Debt-to-Equity
02/28/22 - 0.00
11/30/21 - 0.00
08/31/21 - 0.00
Debt-to-Capital
02/28/22 - 0.04
11/30/21 - 0.04
08/31/21 - 0.05
 

Powered by Zacks Investment Research ©